Economic burden of lung cancer recurrence in France

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 418, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Management and Costs of Treating Lung Cancer Patients in a University Hospital

By Dedes K.J.  

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 435-444

Adis International

Access to resources Recommend Favorite

The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation

By  

Current Medicinal Chemistry, Vol. 19, Iss. 20, 2012-07 ,pp. : 3337-3352

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment and Outcomes for Elderly Patients with Small Cell Lung Cancer

By Stephens R.J.  

Drugs & Aging, Vol. 17, Iss. 3, 2000-09 ,pp. : 229-247

Adis International

Access to resources Recommend Favorite

Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US

By Paladino Joseph A.   Adelman Martin H.  

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 677-683

Adis International

Access to resources Recommend Favorite